about
Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramideSphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue.Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposureSphingomyelinases: enzymology and membrane activity.Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.Recent advances in the immunobiology of ceramide.Mitochondrial ceramide and the induction of apoptosisSphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.Sphingolipids in inflammation: pathological implications and potential therapeutic targets.Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction.Red blood cell clearance in inflammation.Identification of staphylococcal enterotoxin B domains involved in binding to cultured human kidney proximal tubular cells: imparting proliferation and death.Role of sphingomyelinases in neurological disorders.Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cellsSphingomyelin degradation is a key factor in dentin and bone mineralization: lessons from the fro/fro mouse. The chemistry and histochemistry of dentin lipidsMolecular cloning, characterization, and expression of a novel human neutral sphingomyelinase.Sphingomyelin metabolism in erythrocyte membrane in asthma.Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
P2860
Q28576262-5D389D6E-7066-4CAB-A8F0-84632851F46FQ33211026-F66A0B67-3D33-4E8E-80D3-7E2E77EB9FEBQ33705468-2C565316-1AA7-49AB-B60B-AF47862930DAQ34156320-1978C7A7-CA8A-4BFD-BBE8-78EFC75C2D44Q34174979-0BFF0208-1557-4649-A946-B99D69EF12F3Q35916828-5228B2FB-98BC-4D22-9E30-CDB20FCBF783Q36259131-4D26A442-B795-4861-8690-5D580963A70CQ36843303-9AFB8162-EC8F-4326-A9E8-248032AF9A3BQ37447464-036873F3-3B0D-4D60-A0D9-51991BD3E01DQ37766094-CE953E75-59B7-4728-9241-AA47CBD24936Q38117135-A8A03402-7C80-4E0B-A37D-63566DE801F6Q38297875-BA16CAC0-1C88-4821-A123-65FC154405F2Q38560939-894E1B01-3472-484E-BC34-4F37CB5E3931Q39656557-4DE1FB02-E0F8-4705-94D9-768A8E470C00Q41683393-92980A5E-741E-441A-AC91-F97542F7F856Q42255988-7036B960-9C6A-4C9E-964A-E6B3DE6B1AC1Q42615715-97ADE833-75C5-4E54-859A-A2F12A97705AQ42835522-1129767D-2C85-4FE9-B031-803FA46D7B0CQ43933924-014E03A7-D62F-49A3-9A2D-9ED2ACB4B3E6
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neutral sphingomyelinase: past, present and future.
@ast
Neutral sphingomyelinase: past, present and future.
@en
Neutral sphingomyelinase: past, present and future.
@nl
type
label
Neutral sphingomyelinase: past, present and future.
@ast
Neutral sphingomyelinase: past, present and future.
@en
Neutral sphingomyelinase: past, present and future.
@nl
prefLabel
Neutral sphingomyelinase: past, present and future.
@ast
Neutral sphingomyelinase: past, present and future.
@en
Neutral sphingomyelinase: past, present and future.
@nl
P1476
Neutral sphingomyelinase: past, present and future.
@en
P2093
Chatterjee S
P356
10.1016/S0009-3084(99)00077-8
P577
1999-11-01T00:00:00Z